Page URL:

'HapMap' genetic data now freely available

17 December 2004
By BioNews
Appeared in BioNews 289

An international consortium that aims to catalogue patterns of human genetic variation has dropped restrictions on the use of its data. The 'HapMap' project, launched in October 2002, is looking at DNA samples from 270 people from around the world, to help uncover the genetic differences linked to illnesses such as heart disease, cancer and diabetes. The information can now be incorporated into other, freely available genetic databases, reports Nature.

The HapMap scientists are looking at genetic markers (SNPs or single nucleotide polymorphisms) that have been inherited together in a block over many generations, indicating that they are physically close to each other. To identify these 'haplotype blocks', researchers will study people originating from China, Nigeria, Japan and the US. Between them, these populations are thought to represent the majority of human genetic variation.

Once catalogued, the haplotype blocks will provide a 'shortcut' for researchers trying to identify genes involved in common diseases. Instead of having to study all of the estimated ten million SNPs, scientists will only have to look at SNPs in key positions within each block. However, when the $100 million HapMap project first began, its organisers were worried that people would attempt to patent certain versions of haplotype blocks. For this reason, users initially had to agree not to do this, and not to share their data with anyone who had not made a similar agreement. This meant that HapMap data could not be placed into any freely available databases.

The restrictions have now been lifted, and although HapMap partners hope that haplotypes related to specific diseases will be commercialised, they also hope that the basic information will remain freely available. Researchers are already using HapMap data to look for genes involved in conditions such as type 2 diabetes, asthma and dyslexia, as well as genes that affect response to certain medications.  An article in last week's Science predicted that the HapMap project will be one 'area to watch' in 2005, saying that it should 'bear fruit' before the end of the year.

Areas to Watch in 2005
Science |  17 December 2004
International HapMap consortium widens data access
Medical News Today |  11 December 2004
Relaxed rules open path to genomic data on disease
Nature |  16 December 2004
15 January 2007 - by Dr Laura Bell 
By Dr Laura Bell: Research published in the journal Nature Genetics last week showed that variation between different ethnic groups, such as susceptibility to certain diseases, may be explained by variable gene expression. Samples collected for the International HapMap Project were used in the study. The HapMap was published last...
28 October 2005 - by BioNews 
An international team of scientists has published a map of human genetic variation, an achievement they say will speed the search for genes involved in conditions such as diabetes and heart disease. The 'HapMap' project, launched in 2002 by the International HapMap consortium, is looking at DNA samples from 270...
21 February 2005 - by BioNews 
US researchers have published a detailed map of key variations in our genetic make-up, information they say will help pinpoint genes involved in many common diseases. The team, based at Californian firm Perlegen Sciences, has identified and studied 1.58 million genetic 'markers' in 71 people from three different populations. The...
5 January 2004 - by BioNews 
An international consortium that aims to catalogue patterns of human genetic variation has published a detailed description of its approach, partly to ensure that all the scientists involved receive credit for their work. The 'HapMap' project, launched in October 2002, is looking at DNA samples from 270 people from around...
4 November 2002 - by BioNews 
Scientists from six countries are to begin work on a major new project to identify human genetic variations associated with common diseases, it was announced last week. The US National Institutes of Health (NIH) has secured funding of $100 million over the next three years for the work, which has...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.